文献速递妇科

一种「预制结」宫腔镜下左炔诺孕酮宫内缓释系统缝线固定新方法

A novel method of "Pre-fabricated Knot" hysteroscopic levonorgestrel-releasing intrauterine system suture fixation.
PubMed 文献 · Fertil Steril · 2025-11-13

本文介绍一种使用「预制结」的宫腔镜下缝线固定技术,用于子宫腺肌病治疗中左炔诺孕酮宫内缓释系统的放置。手术在10分钟内完成,无出血,术后2小时出院,无并发症;截至2025年4月至8月已完成17例手术,未观察到脱落或并发症,症状缓解初步良好。作者认为该技术疗效相当、手术时间缩短、安全性提高,但目前适应证应限于伴有贫血、痛经和月经过多的子宫腺肌病患者,尤其是有宫内节育器脱落史者,未来需延长随访和扩大样本量进一步评估长期结局。

要点

  • 预制结缝线固定左炔诺孕酮宫内缓释系统于子宫后壁,手术10分钟完成,无出血。
  • 术后2小时出院无并发症,1个月随访痛经和月经过多改善。
  • 2025年4月至8月共完成17例手术,至今未观察到脱落或并发症。

核心结论

  • 该技术疗效相当、手术时间缩短、安全性提高,因其操作步骤简化。
  • 目前其适应证应限于伴有贫血、痛经和月经过多的子宫腺肌病患者,尤其是有宫内节育器脱落史者。
  • 未来需延长随访期和扩大患者队列进一步评估该技术的长期结局。

研究设计与样本

  • 分步视频展示「预制结」宫腔镜下左炔诺孕酮宫内缓释系统缝线固定技术,研究经国际和平妇幼保健院机构审查委员会批准,患者知情同意。
  • 研究对象为一名48岁未产女性,诊断为子宫腺肌病,严重痛经和月经过多近7年,症状在过去6个月加重。
  • 既往治疗包括高强度聚焦超声消融和正在进行的地诺孕素治疗,实验室检查示轻度贫血,经阴道超声示子宫球形增大相当于妊娠14周。
  • 患者因强烈保留生育意愿拒绝子宫切除术。
  • 经阴道超声用于评估治疗前后子宫体积和左炔诺孕酮宫内缓释系统位置,患者在3个月米非司酮疗程后接受手术。

主要发现

  • 左炔诺孕酮宫内缓释系统在10分钟内成功固定于子宫后壁,无出血。
  • 患者术后2小时出院,无并发症。
  • 1个月随访时,患者报告痛经和月经过多改善。
  • 目前自2025年4月至8月已完成17例手术,至今未观察到脱落或并发症病例。
  • 此外,已观察到症状缓解的初步阳性结果。

临床怎么用

  • 作者认为该技术疗效相当、手术时间缩短、安全性提高,因其操作步骤简化。
  • 作者认为目前其适应证应限于伴有贫血、痛经和月经过多的子宫腺肌病患者,尤其是有宫内节育器脱落史者。
  • 作者建议未来需延长随访期和扩大患者队列进一步评估该技术的长期结局。

局限性

  • 未来需延长随访期和扩大患者队列进一步评估该技术的长期结局。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: To introduce a novel hysteroscopic suture fixation technique using a "pre-fabricated knot". This is used for levonorgestrel-releasing intrauterine system placement in adenomyosis treatment. DESIGN: Step-by-step video of "pre-fabricated knot" hysteroscopic levonorgestrel-releasing intrauterine system suture fixation. The study was approved by the Institutional Review Board of the International Peace Maternity and Child Health Hospital. Informed consent was obtained from the patients. SUBJECTS: A 48-year-old nulliparous female diagnosed with adenomyosis suffering from severe dysmenorrhea and menorrhagia for nearly 7 years. The symptoms worsened over the past 6 months. Previous treatments included high-intensity focused ultrasound ablation and ongoing dienogest therapy. Laboratory tests revealed mild anemia, and transvaginal ultrasound showed a globular uterine enlargement equivalent to a 14-week gestation. The patient declined a hysterectomy because of a strong fertility preservation desire. EXPOSURE: Transvaginal ultrasonography was used to assess the uterus volume and the position of the levonorgestrel-releasing intrauterine system before and after treatment. The patient underwent the operation after a 3-month course of mifepristone. After preparatory curettage, the levonorgestrel-releasing intrauterine system was fixed within the uterine cavity using a suture with prefabricated, bead-like knots, thereby achieving the effect of anchoring the device, preventing it from falling off. MAIN OUTCOME MEASURES: Safety and efficiency of this novel technique. RESULTS: The levonorgestrel-releasing intrauterine system was successfully fixed on the posterior uterine wall in 10 minutes with no blood loss. The patient was discharged 2 hours after the operation without complications. At 1-month follow-up, she reported that her dysmenorrhea and menorrhagia had improved. Currently, we have completed 17 surgeries from April to August 2025. To date, no cases of expulsion or complications have been observed. Furthermore, we have observed preliminary positive outcomes in symptom relief. CONCLUSION: The technique offers equal efficacy, reduced operative time, and enhanced safety because of its simplified procedural steps. However, its indication should currently be limited to adenomyosis patients with anemia, dysmenorrhea, and menorrhagia, particularly those with a history of intrauterine device expulsion. Future studies with extended follow-up periods and larger patient cohorts are warranted to further evaluate the long-term outcomes of this technique.

来源:Fertil Steril,查看原文。版权归原作者所有。

引用

  1. Pan Y, Ni T, Wang S, et al. A novel method of "Pre-fabricated Knot" hysteroscopic levonorgestrel-releasing intrauterine system suture fixation. Fertil Steril. 2025. PMID: 41241267. doi:10.1016/j.fertnstert.2025.11.010

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。